Program name: Summer Student Research Scholarships in Psoriatic Diseases
Funding organizations: Canadian Association of Psoriasis Patients (CAPP) *Additional funders will be added to this RFA as they commit to this program
Application Deadline: Friday, February 22nd, 2019
Anticipated Notice of Decision: March 29th, 2019
Funding Start Date: May 1st, 2019
The purpose of this funding opportunity is to provide undergraduate and health professional students with opportunities to undertake research projects related to psoriatic diseases with established investigators in an environment that provides strong mentorship. We encourage applications from across Canada.
The total amount available for this funding opportunity is $20,000 (up to 5 awards.) The number of awards may increase if additional funding partners participate. The maximum stipend contribution per award is $4,000 for up to three months (timelines are flexible to accommodate school schedules. Minimum is eight weeks.)
This opportunity targets the early stage of the student’s academic training to encourage the pursuit of a career in psoriatic disease research and/or in medical dermatology.
Eligibility to Apply
For your application to be eligible:
1. The Nominated Principal Applicant must be a trainee. The trainee must meet the following requirements:
a. Enrollment in a medical school or health professional program at a Canadian university at the time of application.
b. Have completed the course requirements of at least the first year of university study (or two academic terms) by the funding start date.
2. At least one project participant must be a Primary supervisor. The Supervisor must meet the following requirements:
a. Be employed by a Canadian institution considered eligible under CIHR's guidelines. Please see CIHR's Grants and Awards Guide for more information.
b. If a Supervisor is affiliated with more than one application, each application must contain a separate and distinct research project.
3. The application must meet the specific requirements described below.
Applicants can submit proposals in the Official Language of their choice and we are committed to ensuring high quality review of applications submitted in either Official Language.
The awards consist of a stipend.
Awardees should review the Use of Grant Funds section of the Tri-Agency (CIHR, NSERC and SSHRC) Financial Administration Guide for a complete listing and description of allowable costs and activities.
Conditions of Funding
Successful applicants funded through this funding opportunity and any other persons working on the project must comply fully with the CIHR Funding Policies.
Policies and guidelines cover areas such as Applicant Responsibilities, Official Languages policy, Access to Information and Privacy Acts, and Acknowledgement of CIHR's Support. Successful applicants will be informed of any special financial requirements prior to the release of funds.
Access to Information Act and Privacy Act, and the Personal Information Protection and Electronic Documents Act (PIPEDA)
While respecting the application of the Privacy Act to federal entities, all signing parties involved in a collaborative agreement will also be bound by the Personal Information Protection and Electronic Documents Act (PIPEDA). All personal information (as identified by the PIPEDA) collected, used or disclosed in the course of any commercial activity under collaborative agreements related to the Funding opportunity will be collected, used and disclosed in compliance with the PIPEDA.
Funding recipients are required to acknowledge the Canadian Association of Psoriasis Patients (CAPP) and any additional funding partners in any communication or publication related to the project. The contributing collaborators/partners will be identified on the decision letter.
CAPP also requests that funded students provide a list of publications and/or presentations related to the research project on an annual basis.
Review Process and Evaluation:
Relevance Review Process
This award is to fund applications that are specific to psoriatic disease research. Applications that are not deemed to be relevant to psoriatic diseases will be withdrawn from the competition. Relevancy review will take place at the same time as the adjudication of the application by the review panel.
Eligible applications will be evaluated using the following review criteria:
• Academic excellence and research interests of the student;
• Excellence of the research project and relevance to psoriatic diseases;
• Quality of the mentoring plan and training environment;
• Suitability of the supervisor and appropriateness of the student for the award;
• The track record of the supervisor as a principal investigator in psoriatic disease research
Upon completion of the review, CAPP will receive the ratings for the applications from the Committee. Applications will be funded from the top down in order of ranking as far as the budget will allow.
How to Apply
The application must be a single PDF document, minimum 12 font, single spaced, with one inch margins consisting of the following sections:
1. Student/supervisor/project information page (Front page: maximum one page): List the following information: A. Project title. B. Student’s name and status in current academic program. C. Supervisor’s name and current employment. D. Research activity location F. Funding period requested. G. Signatures of both student and supervisor.
2. Summary of project (maximum one page): Describe the project, hypothesis, and specific objectives that the trainee will undertake.
3. Relevance to psoriatic diseases: (maximum ½ page): Note that only projects relevant to psoriatic diseases will be funded.
4. Lay title and lay summary (maximum ½ page): This section should be suitable for a press release and/or for the CAPP website to attract funders/donors.
5. Mentorship plan (maximum one page): Supervisor should outline the research activities of the student, detail a mentoring plan that will enable the student to achieve these objectives, and specify which funds will be used to support the research. Details should include who will directly supervise the student, how often the student will meet with the supervisor, and plans for the student to present their research. Importantly, the specific funding agency, the title of the grant, and the fund number of the grant used to support this research should be detailed.
6. CV of student (maximum 5 pages): Summarize current academic and research achievements. List all research presentations, abstracts and publications.
7. CV of supervisor (maximum 5 pages, limit publications and funding history to last 5 years): Summarize academic and/or employment history. List all publications and funding in the last five years. Include a section detailing significant contributions to the field of psoriatic arthritis.
8. Student transcripts needed ONLY AFTER approved for funding: Official transcripts from the University should be sent directly to Kathryn Andrews-Clay, Executive Director, Canadian Association of Psoriasis Patient, 111-223 Colonnade Road, Ottawa, ON, K2E 7K3.
Specific Conditions of Funding/Knowledge Translation
The funded students, at the end of the funding period are invited to apply for an additional $1,000 travel award. This award is designed to help students present their research findings at National or International conferences. Students are asked to send a letter or request to the address listed below along with confirmation of acceptance at any applicable conference.
For questions on how to apply, and the peer review process contact:
Canadian Association of Psoriasis Patients
111-223 Colonnade Road, Ottawa, ON K2E 7K3
Canadian Association of Psoriasis Patients
The Canadian Association of Psoriasis Patients was formed to better serve the needs of psoriasis patients across the country. We are a subsidiary of the Canadian Skin Patient Alliance and strive to improve the quality of life for all Canadian psoriasis patients. Our mission is to be a resource for psoriasis patients and their families by providing support and education and raising awareness about the effects of psoriasis to improve patient care and quality of life.